About | Free Trial

Last Update

2015-10-22T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Pamela Hay?

Ms. Pamela Hay A.

Co-Founder and President

Visgo

Direct Phone: (617) ***-****       

Email: p***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Company Description

Visgo is developing best in class products to treat joint diseases, such as osteoarthritis. These products will be locally delivered using the Company's proprietary, joint friendly delivery platform to release drugs over time. Its first product, VG201, wi ... more

Find other employees at this company (3)

Background Information

Employment History

Partner

Red Sky Partners, LLC.

Senior Vice President

Dyax Corp.

Chief Commercial Officer

Domantis Limited

Senior Legal Positions

Biogen Idec Inc.

Senior Legal Positions

T Cell Sciences

Consultant

Biotechnology Business Strategy Consulting

General Counsel

AVANT Immunotherapeutics , Inc.

Affiliations

Advisor
NeuroHealing Pharmaceuticals Inc

Education

biology

Cornell

B.A.

Biology

Cornell University

J.D.

Biology

University of Wisconsin Law School

JD

University of Wisconsin

Ms Hay

Dyax Corp.

Ms Hay

T Cell Sciences and Corporate Counsel

law degree

University of Wisconsin

Web References (32 Total References)


Pamela Hay PhD, Business ...

www.anelixistherapeutics.com [cached]

Pamela Hay PhD, Business Development

...
Pamela Hay PhD, Business Development Dr. Hay has more than 25 years of business development and legal experience working in private and public biotechnology companies. She is a partner at Red Sky Partners, a business advisory firm to the health care industry that provides strategy and transaction advice and interim management services to private and public biotech and biopharma companies.


Team - Red Sky Partners

www.redskyco.com [cached]

Pamela Hay

Lead negotiator on more than 100 licensing, partnering and M&A life sciences deals, including managing the selling, buying and diligence processes. Headed business development, legal and IP functions at private and public biotech companies, including during private and IPO financings. Previously held CBO and senior management roles at Domantis, Dyax, Avant and Biogen, and has been a business strategy consultant for several biotech companies. Co-founder and President, Visgo Therapeutics, Inc. BA in Biology from Cornell University; JD from the University of Wisconsin School of Law
photo: Pamela Hay


News & Headlines: Diversys Names Pamela Hay Chief Commercial Officer

www.otohns.net [cached]

2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer. Ms. Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company.

...
Ms. Hay has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies. With a degree in biology from Cornell and a law degree from the University of Wisconsin. She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities. Within Dyax, Ms. Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use. In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio. Ms. Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts. This article was prepared by Health & Medicine Week editors from staff and other reports.


NeuroHealing Pharmaceuticals Inc.

www.NHpharma.com [cached]

Pamela Hay, J.D.

...
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the company's purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.


Domantis

www.domantis.com [cached]

Pamela Hay Chief Commercial Officer Tel: +1 617 225 0600 (US)pamela.hay@domantis.com

Similar Profiles

Other People with this Name

Other people with the name Hay

Tommy Hay
Clean Air Radon Solutions

Andrew Hay
myVet

Graham Hay
UK Industrial Service

Michelle Hay
Forget Me Not

Gary Hay
Business Networking International Henderson Chapter

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory